The MAPK/ERK pathway is among the activated oncogenic pathways in medulloblastoma and its blockade is associated with decreased proliferation, stemness, and invasion in medulloblastoma cells [49, 50]. The gene discussed is MAPK1; the disease is medulloblastoma.